<!doctype html>

<html lang="en">
<head>
    <meta charset="utf-8">
    <meta content="IE=edge" http-equiv="X-UA-Compatible">
<!--    <meta content="width=device-width, initial-scale=1.0" name="viewport">-->
    <title>GA TB Reference Guide </title>
    <meta content="GA TB Reference Guide" name="description">
    <meta content="SitePoint" name="author">
    <link href="../assets/uikit.css" rel="stylesheet">
    <link href="../assets/style.css" rel="stylesheet">

</head>

<body>
<div class="uk-container">
    
    <p> View in chapter -> <a href="5_treatment_of_current_(active)_disease_therapy__c__special_clinical_situations.html#table8"> Special Clinical Situations </a></p>
    <div class="uk-overflow-auto"
         id="table_8_first-line_tb_drugs_dosing_for_adults_(ages_16_and_over)_directly_observed_therapy_(dot)_is_mandatory">
        <table class="uk-table uk-table-small uk-table-divider">
            <thead>
            <tr>
                <th rowspan="2">Drugs</th>
                <th colspan="3">Adult Dose based on body weight in kilograms (kg)*
                </th>
                <th rowspan="2" class="uk-table-expand">Adverse Reactions</th>
                <tr>
                    <td class="uk-table-expand"><b>Daily</b></td>
                    <td class="uk-text-nowrap"><b>Thrice-Weekly</b></td>
                    <td class="uk-text-nowrap"><b>Twice-Weekly</b></td>
                </tr>
            </tr>
            </thead>
            <tr>
                <td>Isoniazid</td>
                <td>300 mg</td>
                <td>900 mg</td>
                <td>900 mg</td>
                <td>
                    <ul>
                        <li>Gastrointestinal (GI) upset</li>
                        <li>Liver enzyme elevation</li>
                        <li>Hepatitis</li>
                        <li>Mild effects on central nervous</li>
                        <li>Drug interactions</li>
                    </ul>
                </td>
            </tr>
            <tr>
                <td>Rifampin</td>
                <td>600 mg</td>
                <td>600 mg</td>
                <td>600 mg</td>
                <td rowspan="2">
                    <ul>
                        <li>Orange discoloration of body fluids and secretions</li>
                        <li>Drug interactions</li>
                        <li>GI upset</li>
                        <li>Hepatitis</li>
                        <li>Bleeding problems</li>
                        <li>Influenze-like symptoms</li>
                        <li>Rash</li>
                        <li>Uveitis (rifabutin only)</li>
                    </ul>
                </td>
            </tr>
            <tr>
                <td>Rifabutin</td>
                <td>300 mg</td>
                <td>Not recommended</td>
                <td>Not recommended</td>
            </tr>
            <tr>
                <td rowspan="3">Pyrazinamide**</td>
                <td>40-55 kg: 1000 mg</td>
                <td>40-55 kg: 1500 mg</td>
                <td>40-55 kg: 2000 mg</td>
                <td rowspan="3">
                    <ul>
                        <li>GI upset</li>
                        <li>Joint aches</li>
                        <li>Hepatitis</li>
                        <li>Rash</li>
                        <li>Hyperuricemia</li>
                        <li>Gout (rare)</li>
                    </ul>
                </td>
            </tr>
            <tr>
                <td>56-75 kg: 1500 mg</td>
                <td>56-75 kg: 2500 mg</td>
                <td>56-75 kg: 3000 mg</td>
            </tr>
            <tr>
                <td>76+ kg: 2000 mg</td>
                <td>76+ kg: 3000 mg</td>
                <td>76+ kg: 4000 mg</td>
            </tr>
            <tr>
                <td rowspan="3">Ethambutol**</td>
                <td>40-55 kg: 800 mg</td>
                <td>40-55 kg: 1200 mg</td>
                <td>40-55 kg: 2000 mg</td>
                <td rowspan="3">
                    <ul>
                        <li>Optic neuritis</li>
                    </ul>
                </td>
            </tr>
            <tr>
                <td>56-75 kg: 1200 mg</td>
                <td>56-75 kg: 2000 mg</td>
                <td>56-75 kg: 2800 mg</td>
            </tr>
            <tr>
                <td>76+ kg: 1600 mg</td>
                <td>76+ kg: 2400 mg</td>
                <td>76+ kg: 4000 mg</td>
            </tr>
        </table>
        
        <p>Source: <a href="https://academic.oup.com/cid/article/63/7/e147/2196792?login=trueas">https://academic.oup.com/cid/article/63/7/e147/2196792?login=trueas</a></p>
        
        <p>*Formula used to convert pounds to kilograms: Divide pounds by 2.2 to get kilograms.</p>
        <p>Example: Patient weighs 154 pounds รท 2.2 = 70 kilograms.</p>
        <p>** Calculate pyrazinamide and ethambutol doses using actual body weight. Pyrazinamide and ethambutol dosage
            adjustment is needed in patients with estimated creatinine clearance less than 50 ml/min or those with
            end-stage renal disease on dialysis.</p>
        <p>NOTE: Refer to current drug reference or drug package insert for a complete list of adverse drug reactions
            and drug interactions.</p>


    </div>
</div>
</body>
<script src="../assets/uikit.js" type="text/javascript"></script>
<script src="../assets/uikit-icons.js" type="text/javascript"></script>
</html>
